Results 201 to 210 of about 66,541 (257)
Biomarkers in primary open angle glaucoma
Abstract Glaucoma, a leading cause of blindness worldwide, is currently defined as a disturbance of the structural or functional integrity of the optic nerve that causes characteristic atrophic changes in the optic nerve, which may lead to specific visual field defects over time.
George Kitsos +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Journal of Australia, 2002
Early diagnosis of this otherwise progressive, asymptomatic process is essential.
Ivan, Goldberg +2 more
openaire +2 more sources
Early diagnosis of this otherwise progressive, asymptomatic process is essential.
Ivan, Goldberg +2 more
openaire +2 more sources
Phacotrabeculectomy in Treatment of Primary Angle-closure Glaucoma and Primary Open-angle Glaucoma
Japanese Journal of Ophthalmology, 2004To evaluate the surgical outcome of combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy (phacotrabeculectomy) in patients with primary angle-closure glaucoma (PACG) or primary open-angle glaucoma (POAG).The records of 57 consecutive patients (65 eyes) with PACG or POAG that were treated with ...
Tham, CCY, Lai, JSM, Lam, DSC, Chan, JCH
openaire +4 more sources
Feline primary open angle glaucoma
Veterinary Ophthalmology, 2008AbstractObjectives We have documented the histomorphological features of feline primary open angle glaucoma.Design A retrospective morphologic study of eight affected eyes from eight cats, from 1992 to 2006 extracted from a pathology collection, which includes 4000 feline submissions and 1100 cases of feline glaucoma.Procedure Sections of affected ...
Susan, Jacobi, Richard R, Dubielzig
openaire +2 more sources
Hypothyroidism and Primary Open-Angle Glaucoma
Ophthalmologica, 2000<i>Objective:</i> To test if there is an association between hypothyroidism and primary open-angle glaucoma (POAG) and the utility of routine study of thyroid function in these patients. <i>Methods:</i> The study was conducted in a case-control fashion.
F J, Muñoz-Negrete +4 more
openaire +2 more sources
Experimental Eye Research, 2020
The gut microbiota (GM) and its influence on host metabolism are considered to be an environmental factor that contributes to the progression of many immune and neurodegenerative diseases.
Haijun Gong +6 more
semanticscholar +1 more source
The gut microbiota (GM) and its influence on host metabolism are considered to be an environmental factor that contributes to the progression of many immune and neurodegenerative diseases.
Haijun Gong +6 more
semanticscholar +1 more source
HLA in Primary Open-Angle Glaucoma
International Archives of Allergy and Applied Immunology, 2009Histocompatibility antigen typing was carried out in 50 Caucasian patients with primary open-angle glaucoma (POAG) and 50 Caucasian ocular-normotensive subjects. HLA-A 3 was present in 46%, B7 in 52%, B 12 in 50%, and either B 7 or B 12 in 88% of patients with POAG.
D H, Shin, B, Becker, C E, Bell
openaire +2 more sources
Race and Primary Open-Angle Glaucoma
American Journal of Ophthalmology, 1985A comparison of racial distributions for three groups of patients showed that 115 of 140 patients (81.6%) with open-angle glaucoma, 221 of 392 patients (56.4%) with ocular hypertension, and 1,028 of 2,109 patients (48.7%) in a random sample were black.
M J, Martin +3 more
openaire +2 more sources
Genetics of primary open angle glaucoma
Japanese Journal of Ophthalmology, 2013Glaucoma is a neurodegenerative disease and one of the leading causes of irreversible blindness, affecting over 60 million people worldwide. At the present time, glaucoma is clinically defined, but the exact etiology is unknown. Genetic studies are one approach to identify the molecules and pathways involved in disease pathogenesis.
Mitsuko, Takamoto, Makoto, Araie
openaire +2 more sources
Optineurin in primary open angle glaucoma
Ophthalmology Clinics of North America, 2003The authors' initial estimate indicated that mutations in Optineurin are responsible for a significant proportion of LPG/POAG families. Currently, there are up to 1.2 million persons with LPG and up to 2.47 million persons with POAG in the United States alone.
Mansoor, Sarfarazi, Tayebeh, Rezaie
openaire +2 more sources

